We use some essential cookies to make this website work.
We’d like to set additional cookies to understand how you use GOV.UK, remember your settings and improve government services.
We also use cookies set by other sites to help us deliver content from their services.
You have accepted additional cookies. You can change your cookie settings at any time.
You have rejected additional cookies. You can change your cookie settings at any time.
Departments, agencies and public bodies
News stories, speeches, letters and notices
Detailed guidance, regulations and rules
Reports, analysis and official statistics
Consultations and strategy
Data, Freedom of Information releases and corporate reports
The Government Chemist team have published a report summarising the findings of a ring trial to assess laboratories’ performance in measuring CBD and controlled cannabinoids
The VMD considers that veterinary products containing Cannabidiol are veterinary medicines.
Report examining issues relating to road safety and the use and prescription of medical cannabis.
This tutorial paper offers a review of the common names, abbreviations, regulation, psychoactivity and analytical methodology for the principle cannabinoids
The number of trade marks filed which contain "CBD" either in the trade mark or somewhere in their specification
Letter from Kit Malthouse MP to Professor Owen Bowden-Jones, Chair of the Advisory Council on the Misuse of Drugs (ACMD).
Fifth webinar in the Webinar Series of the Joint Knowledge Transfer Framework for Food Standards and Food Safety Analysis on 29 March 2023
E-seminar covering issues surrounding the use of CBD in food supplements and difficulties likely to be encountered in their analytical testing
The importer and distributor of the above products (Eaststone Limited) has informed us of reports that two affected batches may be contaminated with mould.
Employment Tribunal decision.
Cannabis-based products for medicinal use will be available for specialist doctors to prescribe legally.
Specialist clinicians will be able to legally prescribe cannabis-derived medicinal products by the autumn, Home Secretary Sajid Javid announced today.
The ACMD has recommended that cannabis-derived medicinal products should be placed in Schedule 2 of the Misuse of Drugs Regulations 2001.
The Medicines and Healthcare products Regulatory Agency (MHRA) responses to freedom of information (FOI) requests for week commencing 4 April 2022
Joint VMD and Veterinary Products Committee (VPC) open information day on Wednesday 18 November.
A letter to clinicians from the Chief Medical Officer and NHS England following the rescheduling of legislation to allow the medicinal use of cannabis-based products.
Don’t include personal or financial information like your National Insurance number or credit card details.
To help us improve GOV.UK, we’d like to know more about your visit today. Please fill in this survey.